JPMorgan Chase & Co’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $101M | Buy |
|
|||||
|
2025
Q2 | $86M | Buy |
|
|||||
|
2025
Q1 | $15.5M | Sell |
|
|||||
|
2024
Q4 | $45.8M | Buy |
|
|||||
|
2024
Q3 | $15.2M | Sell |
|
|||||
|
2024
Q2 | $48.9M | Sell |
|
|||||
|
2024
Q1 | $74.7M | Buy |
|
|||||
|
2023
Q4 | $39.2M | Buy |
|
|||||
|
2023
Q3 | $24.7M | Sell |
|
|||||
|
2023
Q2 | $31.7M | Buy |
|
|||||
|
2023
Q1 | $11.4M | Buy |
|
|||||
|
2022
Q4 | $9.73M | Sell |
|
|||||
|
2022
Q3 | $18.7M | Buy |
|
|||||
|
2022
Q2 | $23.9M | Buy |
|
|||||
|
2022
Q1 | $10.5M | Buy |
|
|||||
|
2021
Q4 | $10.3M | Sell |
|
|||||
|
2021
Q3 | $9.75M | Sell |
|
|||||
|
2021
Q2 | $10.3M | Buy |
|
|||||
|
2021
Q1 | $8.01M | Buy |
|
|||||
|
2020
Q4 | $7.17M | Sell |
|
|||||
|
2020
Q3 | $10.5M | Buy |
|
|||||
|
2020
Q2 | $11.4M | Sell |
|
|||||
|
2020
Q1 | $17.2M | Sell |
|
|||||
|
2019
Q4 | $67.4M | Sell |
|
|||||
|
2019
Q3 | $86.4M | Buy |
|
|||||
|
2019
Q2 | $40.4M | Buy |
|
|||||
|
2019
Q1 | $28.4M | Buy |
|
|||||
|
2018
Q4 | $24.1M | Buy |
|
|||||
|
2018
Q3 | $10.4M | Sell |
|
|||||
|
2018
Q2 | $11.3M | Buy |
|
|||||
|
2018
Q1 | $5.71M | Buy |
|
|||||
|
2017
Q4 | $3.44M | Sell |
|
|||||
|
2017
Q3 | $6.18M | Sell |
|
|||||
|
2017
Q2 | $9.33M | Sell |
|
|||||
|
2017
Q1 | $9.48M | Sell |
|
|||||
|
2016
Q4 | $40.8M | Sell |
|
|||||
|
2016
Q3 | $139M | Sell |
|
|||||
|
2016
Q2 | $293M | Sell |
|
|||||
|
2016
Q1 | $424M | Sell |
|
|||||
|
2015
Q4 | $505M | Sell |
|
|||||
|
2015
Q3 | $536M | Buy |
|
|||||
|
2015
Q2 | $385M | Buy |
|
|||||
|
2015
Q1 | $90.8M | Sell |
|
|||||
|
2014
Q4 | $102M | Buy |
|
|||||
|
2014
Q3 | $87.2M | Sell |
|
|||||
|
2014
Q2 | $103M | Sell |
|
|||||
|
2014
Q1 | $103M | Buy |
|
|||||
|
2013
Q4 | $82.5M | Buy |
|
|||||
|
2013
Q3 | $66.3M | Sell |
|
|||||
|
2013
Q2 | $69.8M | Buy |
|